Pro zobrazení tohoto obsahu je třeba být přihlášen.
Categories for Uncategorized
Pembrolizumab Increases Historic Survival Rate for Certain People with Advanced Non-Small Cell Lung Cancer
18 septembra, 2020 8:01 pmJune 1, 2019 “These data are similar to what we have seen in other cancers treated with immunotherapy in that...
Karcinóm pľúc na ASCO© 2019
18 septembra, 2020 8:01 pmÚvod Aj tento rok prinieslo ASCO© 2019 novinky v oblasti karcinómu pľúc v širokom spektre – od klinických štúdií, ktoré môžu zmeniť...
Updated results of TRIBE2, a phase III, randomized strategy study by GONO in the first- and second-line treatment of unresectable mCRC
18 septembra, 2020 8:01 pmAuthors: Chiara Cremolini, Carlotta Antoniotti, Sara Lonardi, et. al. Abstract: 3508 Clinical Trial Registry Number: NCT02339116 Citation:...
APACT: phase III, multicenter, international, open-label, randomized trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P/G) vs gemcitabine (G) for surgically resected pancreatic adenocarcinoma
18 septembra, 2020 8:01 pmAuthors: Margaret A. Tempero, Michele Reni, Hanno Riess, et. al. Abstract: 4000 Clinical Trial Registry Number: NCT01964430 ...
ARTIST 2: Interim results of a phase III trial involving adjuvant chemotherapy and/or chemoradiotherapy after D2-gastrectomy in stage II/III gastric cancer (GC)
18 septembra, 2020 8:01 pmAuthors: Se Hoon Park, Dae Young Zang, Boram Han, et. al. Abstract: 4001 Clinical Trial Registry Number: NCT02494583...
Maintenance Therapy with PARP Inhibitor Olaparib Delays Progression of BRCA-Related Pancreatic Cancer
18 septembra, 2020 8:01 pmJune 2, 2019 “We are eagerly awaiting longer-term data to understand the full impact of the results from this trial....
Front-Line Pembrolizumab Is Promising Alternative to Chemotherapy for Advanced Gastroesophageal Junction and Gastric Cancers
18 septembra, 2020 8:01 pmJune 1, 2019 “Chemotherapy has been our only option for many years. These results introduce a potential alternative in pembrolizumab...
Najvýznamnejšie klinické správy z konferencie ASCO© 2019 v problematike nádorov gastrointestinálneho traktu
18 septembra, 2020 8:01 pmPočas prvého júnového týždňa tohto roku sa konal v Chicagu tradičný výročný kongres Americkej onkologickej spoločnosti (ASCO®). Ako obvykle v rámci prednášok...
Pembrolizumab (pembro) plus axitinib (axi) versus sunitinib as first-line therapy for metastatic renal cell carcinoma (mRCC): Outcomes in the combined IMDC intermediate/poor risk and sarcomatoid subgroups of the phase 3 KEYNOTE-426 study
18 septembra, 2020 8:01 pmAuthors: Brian I. Rini, Elizabeth R. Plimack, Viktor Stus, et. al. Abstract: 4500 Clinical Trial Registry Number: NCT02853331...
EV-201: Results of enfortumab vedotin monotherapy for locally advanced or metastatic urothelial cancer previously treated with platinum and immune checkpoint inhibitors
18 septembra, 2020 8:01 pmAuthors: Daniel Peter Petrylak, Arjun Vasant Balar, Peter H. O’Donnell, et. al. Abstract: LBA4505 Clinical Trial Registry Number:...